Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification
about
A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma.Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial.A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients.The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas.Diagnosis of systemic metastatic retinal lymphoma.Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project.Phenotypic characterization of subsets of T cell lymphoma: towards a functional classification of T cell lymphoma.Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine-melphalan conditioning for treatment of mature T-cell lymphomas.Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification.The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell NeoplasmsIdentification and characterization of peripheral T-cell lymphoma-associated SEREX antigensAutologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey.Stem cell transplantation for peripheral T-cell lymphomas.Bone marrow histopathology in peripheral T-cell lymphomas.How to predict the outcome in mature T and NK cell lymphoma by currently used prognostic models?Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma.Receptor-directed therapy of T-cell leukemias and lymphomas.Long-term complete remission with belinostat in a patient with chemotherapy refractory peripheral T-cell lymphoma.Peripheral T-cell lymphoma presenting as an ischemic stroke in a 23-year-old woman: a case report and review of the literature.Central nervous system involvement in T-cell lymphoma: A single center experience.Stem cell transplantation as a biological therapy for peripheral T-cell lymphomas.Hepatosplenic T-cell lymphoma and inflammatory bowel disease.Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).Peripheral T-cell lymphoma classification: the matter of cellular derivation.Pralatrexate: a novel synthetic antifolate for relapsed or refractory peripheral T-cell lymphoma and other potential uses.A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma.Novel therapies for peripheral T-cell lymphomas.Sonographic appearance of uterine lymphoma: case report and review of the literature.The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell Project.Investigational drugs for T-cell lymphoma.Cerebellar EBV-associated diffuse large B cell lymphoma following angioimmunoblastic T cell lymphoma.Comparative analysis of NK/T-cell lymphoma and peripheral T-cell lymphoma in Korea: Clinicopathological correlations and analysis of EBV strain type and 30-bp deletion variant LMP1.An update in management of noncutaneous T-cell lymphomas.Impact of autologous and allogeneic stem cell transplantation in peripheral T-cell lymphomas.Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy.Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial.High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas.Peripheral T-cell lymphomas: in "real life" experience are we really improving?T-cell non-Hodgkin's lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factors.Combination of 13-cis retinoic acid and interferon-alpha in the treatment of recurrent or refractory peripheral T-cell lymphoma.
P2860
Q33418737-B1FD5DD8-B5DD-4C1B-B809-81CE3447FB57Q33425005-D82872F5-BA21-4F54-BEE2-F09A49C4896EQ33431457-54FFFF04-A945-4CE2-AB3D-B377CB462B79Q33702181-A1B1C7BF-05B3-43F0-97C4-E9A4A0CFA542Q33940200-78AB1859-12AB-4E4B-BE3F-36FDF49F6840Q34273167-D6C2DB6F-E5C6-42B6-8FF2-312246076785Q34293431-51EF7559-1A65-496E-8CC7-400DB689F96CQ35087581-FE4D15F2-5A8C-4276-A3EE-4F372C4D5518Q35104376-F2446B42-810D-49CB-AE4B-18F3178ECC3CQ35163220-C4C74E9F-E442-467D-90B1-30EFDC299742Q35181261-B0828AEF-DCC5-4233-8A75-7081C3DA5E29Q35608203-A2F76CBE-4D53-48E2-BAB1-1B72B2754289Q35782523-1BDCE357-E052-4C9F-A0B3-D26FE2995730Q35907086-AD4B9CEA-4272-4234-BB02-2E70C49F5141Q36355093-DA4F8FD8-113D-45BA-AF3A-CA42AE0BAD29Q36499270-AAEDA544-8F60-4224-A403-B0203FE51C8DQ37196716-7E7A923F-D49F-40B2-9EC9-70A9443A25ACQ37355651-90960F97-90D2-46E2-83AE-9ADB86D3EF13Q37641113-E5B47751-ED1A-4669-9382-8730967FE7EAQ37733139-E24AC92E-1BBE-4D9B-AA64-7F01E1CE11FEQ37809085-D97EBF8A-9E45-4757-8F3E-9362252C62F4Q37814566-70B5ADDA-F702-4AB5-B605-8E9CAF195D37Q37863688-D890E6DB-BD58-4A68-B306-3F6AEFDD1C48Q37908157-152D5ACD-394E-4CCD-8946-4611337AEF23Q37940292-6259BD8E-6D53-4E1B-B8ED-1FA760C18A9EQ37956318-9A521A4A-BC1B-43B5-A876-32B54AC1FA2BQ38111388-DAB73015-2191-4C8D-AFA7-C777299051F0Q38209377-780078B8-ECFE-4F2C-B5F6-4F78690AFABAQ38602677-BD4E86A6-D55E-4662-91D2-B84377444012Q38635909-6D9C22DE-CBA7-43E2-9EBA-EA68D5CDB101Q40608149-3FDED893-B095-43B4-82F9-E600F5A61CD2Q40615052-4FCEBC4D-EDB5-4321-9A45-98BA265C70EDQ41215812-55D8BEE9-08FC-46E6-BB06-55C49C14C8B3Q41928592-7C8E95FD-F943-4C48-88C5-16A0BE32F425Q43254038-895449FB-6FCB-4B91-991B-AA52A5EC3C74Q43473775-4038FB52-C8BD-48BE-B226-73BA1374910AQ43613022-70F70248-EEEF-480C-B5B1-8EC6C7D646FBQ43696519-2D2455CA-D7B8-43D4-9423-B272887C2308Q44086093-E01236D7-9628-461A-A988-4C5FB84BC035Q44186540-D36E4B05-632B-45DA-A44F-94799BF2F670
P2860
Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification
description
im August 1998 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 August 1998
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 1998
@uk
name
Peripheral T-cell lymphomas: I ...... to the R.E.A.L. Classification
@en
Peripheral T-cell lymphomas: I ...... to the R.E.A.L. Classification
@nl
type
label
Peripheral T-cell lymphomas: I ...... to the R.E.A.L. Classification
@en
Peripheral T-cell lymphomas: I ...... to the R.E.A.L. Classification
@nl
prefLabel
Peripheral T-cell lymphomas: I ...... to the R.E.A.L. Classification
@en
Peripheral T-cell lymphomas: I ...... to the R.E.A.L. Classification
@nl
P2093
P50
P356
P1433
P1476
Peripheral T-cell lymphomas: i ...... to the R.E.A.L. Classification
@en
P2093
A Fernández de Sevilla
A López-Guillermo
C Montalbán
E Montserrat
J García-Conde
J M Castrillo
J M Ribera
P304
P356
10.1023/A:1008418727472
P577
1998-08-01T00:00:00Z